Q: Hi, My current exposure to the health care sector is less than 2%. I am considering increasing my position to approximately 5% by means of etf (I currently own GUD and GILD approx 1% each). I am considering XLV or IBB for etfs. Which of these (or) any other etf you would recommend? I noted that IBB seems more volatile than XLV when I compared them..I was wondering why?
You can view 3 more answers this month. Sign up for a free trial for unlimited access.
Investment Q&A
Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.
Q: knight, has been trending lower, is this because he is slow deploying the 600 million of cash or am i missing something. dave
Q: What are your thoughts on this company. Significant price correction recently. Is it a good entry point for a long term, 10yr, investment? Thx
Q: Up 10% today. See any reason why?
Thanks
Sheldon
I have a question about 1014
Thanks
Sheldon
I have a question about 1014
Q: Hi 5i,
I am an unforunate holder of EDT. It is recently crashed to earth and had an immediate "dead cat bounce."
I have read your other answers on this stock.
I was thinking it was dead money but it has been rising quite nicely since the "dead cat bounce." Up over 7% today.
I am wondering weather to hang on, or claim my losses now.
I would appreciate any comments you have.
I am an unforunate holder of EDT. It is recently crashed to earth and had an immediate "dead cat bounce."
I have read your other answers on this stock.
I was thinking it was dead money but it has been rising quite nicely since the "dead cat bounce." Up over 7% today.
I am wondering weather to hang on, or claim my losses now.
I would appreciate any comments you have.
Q: Are things getting any clearer yet as to the survivability of Valeant? Have any of their proposed sales brought buyers, and do you think they can meet their short term obligations to give them time to regroup?
Q: I have a position in Gilead and have set a target price of $70(US) to add to my holding. Would you agree with this position? Thanks for your advice on this matter
Q: Could I please have your comments on this stock. I am considering it for a long term investment. It is a top holding in the Mawer Global Equity fund. Is there another US stock in this sector that you would prefer? Thanks Brian
-
CVS Health Corporation (CVS)
-
Danaher Corporation (DHR)
-
Johnson & Johnson (JNJ)
-
Extendicare Inc. (EXE)
-
CRH Medical Corporation (CRH)
-
Novo Nordisk A/S (NVO)
Q: Good day,
I know that your focus is not the US but the landscape is changing with the election so perhaps you could just be a sounding board. I have a large position in JNJ (for growing yield and broad diversification), a full position in EXE (for yield), and a 3% position in CRH (for growth). JNJ trades at a premium, justly so. I was thinking of swapping these holdings except maybe EXE for CVS, NVO and DHR. DHR is now focused since its spin off of Fortive and has been a long-term outperformer (it is devices and consumables). NVO (drugs) and CVS (broad healthcare) are great growth stocks that are beaten down compared to JNJ and together offer comparable yields. What would be your thoughts?
Thanks!
Derek
I know that your focus is not the US but the landscape is changing with the election so perhaps you could just be a sounding board. I have a large position in JNJ (for growing yield and broad diversification), a full position in EXE (for yield), and a 3% position in CRH (for growth). JNJ trades at a premium, justly so. I was thinking of swapping these holdings except maybe EXE for CVS, NVO and DHR. DHR is now focused since its spin off of Fortive and has been a long-term outperformer (it is devices and consumables). NVO (drugs) and CVS (broad healthcare) are great growth stocks that are beaten down compared to JNJ and together offer comparable yields. What would be your thoughts?
Thanks!
Derek
Q: hello 5i:
Regarding the recently issued 5 1/2 year Senior Notes (9% yield). Can you quantify the risk? Can you also give a detailed description of these notes please
thanks
Paul L
Regarding the recently issued 5 1/2 year Senior Notes (9% yield). Can you quantify the risk? Can you also give a detailed description of these notes please
thanks
Paul L
Q: Could you please comment on ARZ's drug right's acquisition this morning. Thanks
Q: What do you think of Cynapsus?
Q: HELLO, CAN YOU PLEASE ADVISE IF IT IS BETTER TO ADD ON TO GILD OR BMY AT THIS TIME. THANKS
Q: What do you think of Theratechnologies at this time?
best,
linda
best,
linda
Q: Who's buying CXR? Up for a second day.
Carl
Carl
Q: What are the four or more good reasons to own Gilead Sciences today? What are their Pipeline or new drugs coming like today? What will their future best selling drug in revenues be?
Q: I hold NHC with a 40% drop should I continue to hold it or cash it in an buy CRH. I also own GUD(up 40%) in the sector. What would you recommend? Thank you
Q: Could I please get your opinion on Nuvo (NRI.to). Thanks.
Q: What do you think of the prospects for BIOASIS technologies?
best,
Linda
best,
Linda
Q: An article in the Globe w.r.t Segregated Fund.
Can you help me to understand how can Segregated fund guarantee to retain principle of invested money? Can you suggest such funds to invest in. Also, I am considering to increase my investment in healthcare stocks, I have EXE, HIG.un, considering NWH.un, CSH.un and NHC. Would appreciate your help to select, perhaps others you can suggest.
Regards, J.A.P. Burlington
Can you help me to understand how can Segregated fund guarantee to retain principle of invested money? Can you suggest such funds to invest in. Also, I am considering to increase my investment in healthcare stocks, I have EXE, HIG.un, considering NWH.un, CSH.un and NHC. Would appreciate your help to select, perhaps others you can suggest.
Regards, J.A.P. Burlington